Dementia and Alzheimer's disease doctors share the symptoms they would always take seriously including forgetfulness, mood ...

The VasCog-2-WSO criteria revise the original VasCog criteria for diagnosing VCID, offering additional guidance on neuroimaging and fluid biomarkers.

Dementia affects more than 6 million Americans and U.S. cases are expected to double by 2060, so it’s worth knowing when to ...

Michael Borrie, physician and medical director of the Aging and Memory Clinic at St. Joseph’s Health Care London, said Health ...

New results on the oral Alzheimer's pill, valiltramiprosate, claims it can slow down the brain atrophy that causes ...

A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

A psychologist has explained precisely what 'mixed dementia' means in an effort to clarify a common misconception. Dr Kelynn Lee, CEO of the Dementia Care Hub, has dedicated her career to researching ...

Health Canada has authorized a drug shown to slow the progression of Alzheimer's disease. Lecanemab is the first medication ...

It's often termed 'mild cognitive impairment' (MCI) as the symptoms are not severe enough to be diagnosed as dementia. "You might not notice these symptoms if you have them, and family and friends may ...

A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...